Inovio Pharmaceuticals
INO
#8897
Rank
NZ$0.24 B
Marketcap
NZ$3.58
Share price
2.48%
Change (1 day)
-47.57%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): NZ-$4.80

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.99. In 2024 the company made an earnings per share (EPS) of NZ-$6.84 an increase over its 2023 EPS that were of NZ-$10.54.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.80-29.74%
2024NZ-$6.84-35.14%
2023NZ-$10.54-56.62%
2022NZ-$24.30-19.54%
2021NZ-$30.2135.9%
2020NZ-$22.23-11.57%
2019NZ-$25.1315.24%
2018NZ-$21.81-2.78%
2017NZ-$22.436.93%
2016NZ-$20.98134.88%
2015NZ-$8.93-29.51%
2014NZ-$12.67-57.34%
2013NZ-$29.70146.55%
2012NZ-$12.0520.83%
2011NZ-$9.97-29.41%
2010NZ-$14.12-48.48%
2009NZ-$27.4210%
2008NZ-$24.9311.11%
2007NZ-$22.43-41.3%
2006NZ-$38.22-66.91%
2005NZ-$115.49110.61%
2004NZ-$54.84-61.63%
2003NZ-$142.91186.67%
2002NZ-$49.85
2001N/A-100%
2000NZ-$39.88-63.64%
1999NZ-$109.68

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.98-159.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$18.07-462.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ-$2.16-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.74-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$13.14-363.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$6.22-224.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
NZ$11.29-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA